Avalon GloboCare (ALBT) Competitors $2.72 -0.07 (-2.33%) As of 01:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALBT vs. JATT, BIVI, QTTB, MTEX, CARM, BLRX, ERNA, AYTU, LGVN, and IMNNShould you be buying Avalon GloboCare stock or one of its competitors? The main competitors of Avalon GloboCare include JATT Acquisition (JATT), BioVie (BIVI), Q32 Bio (QTTB), Mannatech (MTEX), Carisma Therapeutics (CARM), BioLineRx (BLRX), Ernexa Therapeutics (ERNA), Aytu BioPharma (AYTU), Longeveron (LGVN), and Imunon (IMNN). These companies are all part of the "pharmaceutical products" industry. Avalon GloboCare vs. Its Competitors JATT Acquisition BioVie Q32 Bio Mannatech Carisma Therapeutics BioLineRx Ernexa Therapeutics Aytu BioPharma Longeveron Imunon JATT Acquisition (NYSE:JATT) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment. Which has stronger valuation & earnings, JATT or ALBT? JATT Acquisition has higher earnings, but lower revenue than Avalon GloboCare. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJATT AcquisitionN/AN/A$6.85MN/AN/AAvalon GloboCare$1.33M3.87-$7.90M-$19.96-0.14 Do insiders and institutionals hold more shares of JATT or ALBT? 48.0% of JATT Acquisition shares are owned by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are owned by institutional investors. 20.0% of JATT Acquisition shares are owned by company insiders. Comparatively, 37.3% of Avalon GloboCare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is JATT or ALBT more profitable? JATT Acquisition has a net margin of 0.00% compared to Avalon GloboCare's net margin of -647.29%. Avalon GloboCare's return on equity of 0.00% beat JATT Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets JATT AcquisitionN/A -49.58% 2.84% Avalon GloboCare -647.29%N/A -50.13% Does the media prefer JATT or ALBT? In the previous week, Avalon GloboCare had 1 more articles in the media than JATT Acquisition. MarketBeat recorded 1 mentions for Avalon GloboCare and 0 mentions for JATT Acquisition. Avalon GloboCare's average media sentiment score of 0.76 beat JATT Acquisition's score of 0.00 indicating that Avalon GloboCare is being referred to more favorably in the news media. Company Overall Sentiment JATT Acquisition Neutral Avalon GloboCare Positive SummaryAvalon GloboCare beats JATT Acquisition on 5 of the 9 factors compared between the two stocks. Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALBT vs. The Competition Export to ExcelMetricAvalon GloboCareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.15M$2.90B$5.50B$9.01BDividend YieldN/A2.64%5.39%4.11%P/E Ratio-0.1421.5027.4220.07Price / Sales3.87282.64398.50109.13Price / CashN/A41.4736.1356.90Price / Book-0.247.518.015.70Net Income-$7.90M-$55.05M$3.16B$248.47M7 Day Performance-21.24%3.05%2.08%2.92%1 Month Performance-22.14%5.80%4.38%5.77%1 Year Performance-64.38%6.15%35.81%21.39% Avalon GloboCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALBTAvalon GloboCare2.2435 of 5 stars$2.73-2.3%N/A-58.2%$5.15M$1.33M-0.145News CoveragePositive NewsJATTJATT AcquisitionN/A$1.13+1.8%N/A-69.4%$19.49MN/A0.003Gap DownHigh Trading VolumeBIVIBioVie0.727 of 5 stars$1.01-1.9%$3.00+197.0%+139.8%$19.13MN/A-0.1310News CoverageGap DownQTTBQ32 Bio2.7628 of 5 stars$1.53-1.3%$12.17+695.2%-92.0%$18.91M$1.16M-0.3139MTEXMannatech0.6034 of 5 stars$9.42-3.9%N/A+30.1%$18.63M$117.87M-94.16250CARMCarisma Therapeutics2.4368 of 5 stars$0.45+2.2%$1.93+326.9%-70.8%$18.43M$19.63M-0.2920News CoverageGap DownHigh Trading VolumeBLRXBioLineRx2.9407 of 5 stars$4.00-5.7%$26.00+550.0%-78.3%$18.07M$28.94M-0.4540News CoverageERNAErnexa Therapeutics0.9637 of 5 stars$2.40-2.0%N/A-92.6%$18.04M$580K-0.2910AYTUAytu BioPharma3.736 of 5 stars$1.98-1.0%N/A-19.9%$17.95M$81M-2.75160News CoverageAnalyst ForecastLGVNLongeveron3.6813 of 5 stars$1.15-4.2%$8.67+653.6%-22.6%$17.91M$2.39M-0.1820Gap DownIMNNImunon2.794 of 5 stars$0.92-9.6%$15.50+1,581.5%-35.5%$17.89M$500K-0.6830Positive News Related Companies and Tools Related Companies JATT Acquisition Competitors BioVie Competitors Q32 Bio Competitors Mannatech Competitors Carisma Therapeutics Competitors BioLineRx Competitors Ernexa Therapeutics Competitors Aytu BioPharma Competitors Longeveron Competitors Imunon Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALBT) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalon GloboCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALBT Stock Alerts